Cough Syrup Dm 15 mg / 5 mL Syrup is a Health Canada–registered human drug (DIN 02229909) held by Stanley Pharmaceuticals, A Division Of Vita Health Products Inc., containing Dextromethorphan Hydrobromide. Health Canada lists its status as Cancelled Pre Market (status date 17 Jul 2017). Nexara Health has matched 472 registrations of Dextromethorphan Hydrobromide across 18 other regulated markets, 13 of them in the same strength and dosage form.

Health Canada registration

Dextromethorphan Hydrobromide registered in other markets

472 registrations of the same molecule in 18 national registries outside Canada (first 94 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Dextromethorphan Hydrobromide worldwide →

Regulator price references for Dextromethorphan Hydrobromide

Published list or reimbursement prices for Dextromethorphan Hydrobromide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Cough Syrup Dm (DIN 02229909) marketed in Canada?

No. Health Canada lists DIN 02229909 as Cancelled Pre Market as of 17 Jul 2017.

Who holds the Canadian licence for this product?

Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. is the company of record in the Health Canada Drug Product Database.

Is Dextromethorphan Hydrobromide registered outside Canada?

Yes — Nexara Health has matched 472 registrations in 18 other markets, including 13 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02229909, status date 2017-07-17; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: DoH SEP database, EDE, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02229909, status date 2017-07-17; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: DoH SEP database, EDE, NHRA, SFDA.

Health Canada Drug Product Database (DPD), DIN 02229909, status date 2017-07-17; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: DoH SEP database, EDE, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.